PortfoliosLab logoPortfoliosLab logo
KO vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KO vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Coca-Cola Company (KO) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KO achieves a 19.04% return, which is significantly higher than NVO's 0.91% return. Over the past 10 years, KO has outperformed NVO with an annualized return of 9.37%, while NVO has yielded a comparatively lower 8.18% annualized return.


KO

1D
0.69%
1M
3.44%
6M
18.14%
YTD
19.04%
1Y
20.90%
3Y*
12.83%
5Y*
10.98%
10Y*
9.37%
ALL TIME*
12.17%

NVO

1D
-1.41%
1M
14.86%
6M
-17.63%
YTD
0.91%
1Y
-19.26%
3Y*
-13.51%
5Y*
4.43%
10Y*
8.18%
ALL TIME*
14.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KO vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
KO
The Coca-Cola Company
19.04%15.60%8.88%-4.43%10.61%11.37%2.47%20.60%6.77%14.38%
NVO
Novo Nordisk A/S
0.91%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between KO and NVO is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Jan 4, 1982

0.19

The correlation between KO and NVO shifts across timeframes, from -0.03 (1 year) to 0.19 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

KO:

$353.32B

NVO:

$220.46B

EPS

KO:

$3.18

NVO:

DKK 27.42

PE Ratio

KO:

25.85

NVO:

11.83

PEG Ratio

KO:

3.12

NVO:

0.51

PS Ratio

KO:

7.19

NVO:

4.40

PB Ratio

KO:

10.53

NVO:

7.11

Total Revenue (TTM)

KO:

$49.28B

NVO:

DKK 327.80B

Gross Profit (TTM)

KO:

$30.43B

NVO:

DKK 268.30B

EBITDA (TTM)

KO:

$18.35B

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KO vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KO
KO Risk / Return Rank: 8080
Overall Rank
KO Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
KO Sortino Ratio Rank: 7777
Sortino Ratio Rank
KO Omega Ratio Rank: 7474
Omega Ratio Rank
KO Calmar Ratio Rank: 8585
Calmar Ratio Rank
KO Martin Ratio Rank: 8282
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 3030
Overall Rank
NVO Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 2929
Sortino Ratio Rank
NVO Omega Ratio Rank: 2929
Omega Ratio Rank
NVO Calmar Ratio Rank: 3232
Calmar Ratio Rank
NVO Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KO vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Coca-Cola Company (KO) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KONVODifference
Sharpe ratioReturn per unit of total volatility

+1.54

Sortino ratioReturn per unit of downside risk

+2.05

Omega ratioGain probability vs. loss probability

1.21

0.97

+0.24

Calmar ratioReturn relative to maximum drawdown

2.67

-0.39

+3.06

Martin ratioReturn relative to average drawdown

5.83

-0.61

+6.44

KO vs. NVO - Sharpe Ratio Comparison

The current KO Sharpe Ratio is 1.17, which is higher than the NVO Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of KO and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

KO vs. NVO - Drawdown Comparison

The maximum KO drawdown since its inception was -68.23%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for KO and NVO.


Loading charts...

Drawdown Indicators


KONVODifference

Max Drawdown

Largest peak-to-trough decline

-68.23%

-74.70%

+6.47%

Max Drawdown (1Y)

Largest decline over 1 year

-7.87%

-49.17%

+41.30%

Max Drawdown (3Y)

Largest decline over 3 years

-16.26%

-74.70%

+58.44%

Max Drawdown (5Y)

Largest decline over 5 years

-17.27%

-74.70%

+57.43%

Max Drawdown (10Y)

Largest decline over 10 years

-36.99%

-74.70%

+37.71%

Current Drawdown

Current decline from peak

-3.30%

-63.95%

+60.65%

Average Drawdown

Average peak-to-trough decline

-16.07%

-17.89%

+1.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.59%

31.75%

-28.16%

Volatility

KO vs. NVO - Volatility Comparison

The current volatility for The Coca-Cola Company (KO) is 7.83%, while Novo Nordisk A/S (NVO) has a volatility of 9.48%. This indicates that KO experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KONVODifference

Volatility (1M)

Calculated over the trailing 1-month period

7.83%

9.48%

-1.65%

Volatility (6M)

Calculated over the trailing 6-month period

14.19%

37.43%

-23.24%

Volatility (1Y)

Calculated over the trailing 1-year period

17.98%

51.79%

-33.81%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.46%

38.58%

-22.12%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.37%

32.63%

-14.26%

Dividends

KO vs. NVO - Dividend Comparison

KO's dividend yield for the trailing twelve months is around 2.53%, less than NVO's 3.63% yield.


PositionTTM20252024202320222021202020192018201720162015
KO
The Coca-Cola Company
2.53%2.92%3.12%3.12%2.77%2.84%2.99%2.89%3.29%3.23%3.38%3.07%
NVO
Novo Nordisk A/S
3.63%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

KO vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between The Coca-Cola Company and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00BOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
12.47B
96.82B
(KO) Total Revenue
(NVO) Total Revenue
Please note, different currencies. KO values in USD, NVO values in DKK

KO vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between The Coca-Cola Company and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%October2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
63.0%
86.0%
Portfolio components
KO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, The Coca-Cola Company reported a gross profit of 7.85B and revenue of 12.47B. Therefore, the gross margin over that period was 63.0%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

KO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, The Coca-Cola Company reported an operating income of 4.36B and revenue of 12.47B, resulting in an operating margin of 35.0%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

KO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, The Coca-Cola Company reported a net income of 3.92B and revenue of 12.47B, resulting in a net margin of 31.5%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


KO and NVO have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVO has higher volatility (9.48%) compared to KO (7.83%). In terms of maximum drawdown, KO dropped -68.23% vs NVO's -74.70%.

KO currently has the higher Sharpe Ratio (1.17 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KO and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer